Management of Charles Bonnet syndrome in routine eye care services
Christoph SE, Boden KT, Siegel R, Seitz B, Szurman P, Schulz A. The prevalence of Charles-Bonnet syndrome in ophthalmic patients: a systematic review and meta-analysis. Brain Res Bull. 2025;223:111282.
Google Scholar
daSilva Morgan K, Collerton D, Firbank MJ, Schumacher J, ffytche DH, Taylor JP. Visual cortical activity in Charles Bonnet syndrome: testing the deafferentation hypothesis. J Neurol. 2025;272:199.
Google Scholar
Teunisse RJ, Cruysberg JR, Verbeek A, Zitman FG. The Charles Bonnet syndrome: a large prospective study in The Netherlands: a study of the prevalence of the Charles Bonnet syndrome and associated factors in 500 patients attending the University Department of Ophthalmology at Nijmegen. Br J Psychiatry. 1995;166:254–7.
Google Scholar
Madill SA, Ffytche DH. Charles Bonnet syndrome in patients with glaucoma and good acuity. Br J Ophthalmol. 2005;88:785–6.
Google Scholar
Forte G, Assaf N, Forte P, Jolly JK. Charles Bonnet Syndrome associated with unilateral vision loss: A new diagnostic perspective. Ophthalmic Physiol Opt. 2025;45:681–8.
Google Scholar
Subhi Y, Nielsen MA, Scott DA, Holm LM, Singh A. Prevalence of Charles Bonnet syndrome in low vision: a systematic review and meta-analysis. Ann Eye Sci. 2022;7:6793.
Google Scholar
Doeller B, Kratochwil M, Sifari L, Hirnschall N, Findl O. Benefit of psychiatric evaluation on anxiety in patients with Charles Bonnet syndrome. BMJ Open Ophthalmol. 2021;6:e000463.
Google Scholar
Cox TM, ffytche DH. Negative outcome Charles Bonnet Syndrome. Br J Ophthalmol. 2014;98:1236–9.
Google Scholar
Higgins B, Taylor D, Crabb D, Callaghan T. Emotional well-being in Charles Bonnet syndrome: exploring associations with negative affect, loneliness and quality of life. Ther Adv Ophthalmol. 2024;16. https://doi.org/10.1177/25158414241275444.
Scott IU, Schein OD, Feuer WJ, Folstein MF. Visual hallucinations in patients with retinal disease. Am J Ophthalmol. 2001;131:590–8.
Google Scholar
Jones L, Ditzel-Finn L, Enoch J, Moosajee M. An overview of psychological and social factors in Charles Bonnet syndrome. Ther Adv Ophthalmol. 2021;13:25158414211034715.
Google Scholar
Mosimann UP, Collerton D, Dudley R, Meyer TD, Graham G, Dean JL, et al. A semi-structured interview to assess visual hallucinations in older people. Int J Geriatr Psychiatry. 2008;23:712–8.
Google Scholar
Cantin S, Duquette J, Dutrisac F, Ponton L, Courchesne M, de Abreu Cybis W, et al. Charles Bonnet syndrome: development and validation of a screening and multidimensional descriptive questionnaire. Can J Ophthalmol. 2019;54:323–7.
Google Scholar
Jones L, Jolly JK, Potts J, Callaghan T, Fisher K, Ip IB, et al. From research to action: recommendations for Charles Bonnet syndrome care and policy. BMJ Open Ophthalmol. 2025;10:e002009.
Google Scholar
Eperjesi F, Akbarali N. Rehabilitation in Charles Bonnet syndrome: a review of treatment options. Clin Exp Optom. 2004;87:149–52.
Google Scholar
Jones L, Ditzel-Finn L, McDonald L, Moosajee M. ‘They’re creepy creatures with human-like features’: children’s experiences of visual hallucinations in Charles Bonnet syndrome—a qualitative study. Arch Dis Child. 2025;110:384–90.
Google Scholar
Dave S, Jones L, Lee M, Ditzel-Finn L, Castle C, Heinze N, et al. The experiences of visually impaired military veterans with Charles Bonnet syndrome. Ther Adv Ophthalmol. 2024;16:25158414241294022.
Google Scholar
Best J, Liu PY, ffytche D, Potts J, Moosajee M. Think sight loss, think Charles Bonnet syndrome. Ther Adv Ophthalmol. 2019;11. https://doi.org/10.1177/2515841419895909.
Strong J. “Playthings of the brain”: phantom visions in Charles Bonnet syndrome. J Gerontol Soc Work. 2019;62:586–96.
Google Scholar
Holroyd S, Sabeen S. Successful treatment of hallucinations associated with sensory impairment using gabapentin. J Neuropsychiatry Clin Neurosci. 2008;20:364–6.
Google Scholar
Coletti Moja M, Milano E, Gasverde S, Gianelli M, Giordana MT. Olanzapine therapy in hallucinatory visions related to Bonnet syndrome. Neurol Sci. 2005;26:168–70.
Google Scholar
Lang UE, Stogowski D, Schulze D, Domula M, Schmidt E, Gallinat J, et al. Charles Bonnet Syndrome: successful treatment of visual hallucinations due to vision loss with selective serotonin reuptake inhibitors. J Psychopharmacol. 2007;21:553–5.
Google Scholar
Ukai S, Yamamoto M, Tanaka M, Takeda M. Treatment of typical Charles Bonnet syndrome with donepezil. Int Clin Psychopharmacol. 2004;19:355–7.
Google Scholar
daSilva Morgan K, Schumacher J, Collerton D, Colloby S, Elder GJ, Olsen K, et al. Transcranial direct current stimulation in the treatment of visual hallucinations in Charles Bonnet syndrome: a randomized placebo-controlled crossover trial. Ophthalmology. 2022;129:1368–79.
Google Scholar
O’Brien J, Taylor JP, Ballard C, Barker RA, Bradley C, Burns A, et al. Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management. J Neurol, Neurosurg Psychiatry. 2020;91:512–9.
Google Scholar
link
